Search Results - "Turaga Kiran"

Are We Harming Cancer Patients by Delaying Their Cancer Surgery During the COVID-19 Pandemic? by Turaga, Kiran K, Girotra, Saket

“…Supplemental Digital Content is available in the text…”
Get full text

Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations by Bartlett, David L., Howe, James R., Chang, George, Crago, Aimee, Hogg, Melissa, Karakousis, Giorgos, Levine, Edward, Maker, Ajay, Mamounas, Eleftherios, McGuire, Kandace, Merchant, Nipun, Shibata, David, Sohn, Vance, Solorzano, Carmen, Turaga, Kiran, White, Richard, Yang, Anthony, Yoon, Sam

Get full text

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma by Panou, Vasiliki, Gadiraju, Meghana, Wolin, Arthur, Weipert, Caroline M, Skarda, Emily, Husain, Aliya N, Patel, Jyoti D, Rose, Buerkley, Zhang, Shannon R, Weatherly, Madison, Nelakuditi, Viswateja, Knight Johnson, Amy, Helgeson, Maria, Fischer, David, Desai, Arpita, Sulai, Nanna, Ritterhouse, Lauren, Røe, Oluf D, Turaga, Kiran K, Huo, Dezheng, Segal, Jeremy, Kadri, Sabah, Li, Zejuan, Kindler, Hedy L, Churpek, Jane E

“…The aim of the current study was to determine the prevalence and clinical predictors of germline cancer susceptibility mutations in patients with malignant…”
Get full text

Importance of Histologic Subtype in the Staging of Appendiceal Tumors by Turaga, Kiran K., Pappas, Sam G., Gamblin, T. Clark

“…Background Malignant neoplasms of the appendix have different behavior based on their histologic subtypes in anecdotal series. Current staging systems do not…”
Get full text

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors by Turaga, Kiran K., Kvols, Larry K.

“…Gastroenteropancreatic neuroendocrine tumors (GEP‐NETs) are relatively rare tumors that arise from the diffuse neuroendocrine system. This heterogeneous group…”
Get full text

Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future by Vining, Charles C., Eng, Oliver S., Hogg, Melissa E., Schuitevoerder, Darryl, Silverman, Rebecca S., Yao, Katharine A., Winchester, David J., Roggin, Kevin K., Talamonti, Mark S., Posner, Mitchell C., Turaga, Kiran K., Tseng, Jennifer

“…Background The COVID-19 pandemic has overlapped with the scheduled interview periods of over 20 surgical subspecialty fellowships, including the Complex…”
Get full text

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis by Helm, Joseph H., Miura, John T., Glenn, Jason A., Marcus, Rebecca K., Larrieux, Gregory, Jayakrishnan, Thejus T., Donahue, Amy E., Gamblin, T. Clark, Turaga, Kiran K., Johnston, Fabian M.

“…Background Due to the increased adoption of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), patients with malignant…”
Get full text

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand? by Witmer, Hunter D. D., Dhiman, Ankit, Turaga, Kiran K.

“…Plain Language Summary Patients with colorectal cancer that has spread to the lining of the abdomen (peritoneum) benefit from surgery to remove all the cancer…”
Get full text

A Systematic Review of Operative Team Familiarity on Metrics of Efficiency, Patient Outcomes, Cost, and Team Satisfaction by Witmer, Hunter D.D., Dhiman, Ankit, Jones, Alonzo D., Laffan, Alison M., Adelman, Dan, Turaga, Kiran K.

“…This study seeks to systematically review the current literature on how surgical team familiarity relates to metrics of operative efficiency. The operating…”
Get full text

Mutational profiles and prognostic impact in colorectal and high‐grade appendiceal adenocarcinoma with peritoneal metastases by Morgan, Ryan B., Dhiman, Ankit, Sood, Divya, Ong, Cecilia T., Wu, Xiaoyang, Shergill, Ardaman, Polite, Blase, Turaga, Kiran K., Eng, Oliver S.

“…Background Next‐generation sequencing (NGS) personalizes cancer treatments. In this study, we analyze outcomes based on NGS testing for colorectal cancer (CRC)…”
Get full text

Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma by Boehm, Lucas M., Jayakrishnan, Thejus T., Miura, John T., Zacharias, Anthony J., Johnston, Fabian M., Turaga, Kiran K., Gamblin, T. Clark

“…Background Hepatic artery based therapies (HAT) are offered for patients with unresectable intrahepatic cholangiocarcinoma (ICC). We aimed to evaluate the…”
Get full text

The Chicago Consensus on peritoneal surface malignancies: Methodology by Plana, Alejandro, Izquierdo, Francisco J., Schuitevoerder, Darryl, Sherman, Scott K., Turaga, Kiran

“…The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of peritoneal surface malignancies of various causes. These…”
Get full text

Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer by Eng, Oliver S., Turaga, Kiran K.

“…As the management of metastatic colorectal cancer (CRC) has evolved over the past decades, optimal management of CRC with peritoneal metastases remains…”
Get full text

ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma by Bansal, Varun V., Mitchell, Owen, Drazer, Michael W., Kindler, Hedy L., Turaga, Kiran K.

Get full text

Primary and metastatic peritoneal surface malignancies by Cortés-Guiral, Delia, Hübner, Martin, Alyami, Mohammad, Bhatt, Aditi, Ceelen, Wim, Glehen, Olivier, Lordick, Florian, Ramsay, Robert, Sgarbura, Olivia, Van Der Speeten, Kurt, Turaga, Kiran K., Chand, Manish

“…Peritoneal surface malignancies comprise a heterogeneous group of primary tumours, including peritoneal mesothelioma, and peritoneal metastases of other…”
Get full text

ASO Author Reflections: Fragmented Care in Patients with Peritoneal Metastases by Vierra, Mason, Bansal, Varun V., Shergill, Ardaman, Turaga, Kiran K., Eng, Oliver S.

Get full text

Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery by Dhiman, Ankit, Kothary, Vishesh, Witmer, Hunter D. D., Bregio, Celyn, Sood, Divya, Ong, Cecilia T., Polite, Blase, Eng, Oliver S., Shergill, Ardaman, Turaga, Kiran K.

“…OBJECTIVETo investigate the role of a personalized, tumor-informed circulating tumor DNA (ctDNA) assay in informing recurrence in patients with peritoneal…”
Get full text

Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation by Berger, Yaniv, Gadiraju, Meghana, Dhiman, Ankit, Gilliam, Katie, Opalecky, Buerkley, Chen, Heather, Helgeson, Maria, Eng, Oliver S., Husain, Aliya N., Drazer, Michael W., Kindler, Hedy L., Churpek, Jane E., Turaga, Kiran K.

“…Background This study aimed to investigate if peritoneal mesothelioma (PM) patients with germline mutations (GM) have distinct surgical characteristics when…”
Get full text

Screening young adults for nonhereditary colorectal cancer by Turaga, Kiran K

Get more information

Peritoneal Metastases in Colorectal Cancer by Jacobson, Richard, Sherman, Scott K., Dadaleh, Fadi, Turaga, Kiran K.

Get full text